Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

Meet 10 trailblazing Black women breaking barriers and driving change across sports, business, healthcare, and leadership.

Patient ID Now, a coalition of leading healthcare organizations, applauds the reintroduction of H.R.2002, the Patient Matching and Transparency in Certified Health IT (MATCH IT) Act of 2025 by ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Stocks took another tumble on Thursday as President Donald Trump escalated the trade war with 200% tariffs on European ...

Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased ...

The president’s deregulatory agenda will mean more responsibility rests on healthcare stakeholders to get artificial ...

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of Hims & Hers’ plan to combine all its dermatology services into one main ...

Shares of HIMS stock opened at $36.01 on Thursday. Hims & Hers Health has a 12-month low of $11.20 and a 12-month high of $72.98. The firm has a market capitalization of $8.00 billion, a price-to ...

Bank of New York Mellon Corp grew its stake in Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 128.7% in the fourth quarter, HoldingsChannel reports.The institutional investor owned ...